BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lahlou H, Guillermet J, Hortala M, Vernejoul F, Pyronnet S, Bousquet C, Susini C. Molecular signaling of somatostatin receptors. Ann N Y Acad Sci. 2004;1014:121-131. [PMID: 15153426 DOI: 10.1196/annals.1294.012] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Smith SW. Drugs and pharmaceuticals: management of intoxication and antidotes. EXS 2010;100:397-460. [PMID: 20358691 DOI: 10.1007/978-3-7643-8338-1_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
2 Vrettos EI, Mező G, Tzakos AG. On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site. Beilstein J Org Chem 2018;14:930-54. [PMID: 29765474 DOI: 10.3762/bjoc.14.80] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 19.3] [Reference Citation Analysis]
3 Zhang Y, Tang Z, Lin W, Yuan X, Jia J, Sun C, Li W. Molecular identification, tissue distribution and functional analysis of somatostatin receptors (SSTRs) in red-spotted grouper (Epinephelus akaara). Gen Comp Endocrinol 2019;274:87-96. [PMID: 30654020 DOI: 10.1016/j.ygcen.2019.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Schonbrunn A. Selective agonism in somatostatin receptor signaling and regulation. Mol Cell Endocrinol. 2008;286:35-39. [PMID: 18006219 DOI: 10.1016/j.mce.2007.09.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
5 Hirose H, Yamasaki T, Ogino M, Mizojiri R, Tamura-Okano Y, Yashiro H, Muraki Y, Nakano Y, Sugama J, Hata A, Iwasaki S, Watanabe M, Maekawa T, Kasai S. Discovery of novel 5-oxa-2,6-diazaspiro[3.4]oct-6-ene derivatives as potent, selective, and orally available somatostatin receptor subtype 5 (SSTR5) antagonists for treatment of type 2 diabetes mellitus. Bioorg Med Chem 2017;25:4175-93. [PMID: 28642028 DOI: 10.1016/j.bmc.2017.06.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
6 Rothenberg M, Pai R, Stuart K. Successful use of octreotide to treat Ménétrier’s disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia. Dig Dis Sci. 2009;54:1403-1407. [PMID: 19255847 DOI: 10.1007/s10620-009-0754-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
7 Yin H, Lee KE, Park SA, Bhattarai JP, Suh BJ, Jeon JG, Kim BG, Park SJ, Han SK. Inhibitory effects of somatostatin on the substantia gelatinosa neurons of trigeminal subnucleus caudalis via somatostatin type 2 receptors in juvenile mice. Brain Research 2009;1304:49-56. [DOI: 10.1016/j.brainres.2009.09.070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
8 Schubert ML, Rehfeld JF. Gastric Peptides-Gastrin and Somatostatin. Compr Physiol 2019;10:197-228. [PMID: 31853955 DOI: 10.1002/cphy.c180035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006;17:1733-1742. [PMID: 16801334 DOI: 10.1093/annonc/mdl105] [Cited by in Crossref: 194] [Cited by in F6Publishing: 167] [Article Influence: 12.9] [Reference Citation Analysis]
10 Qiu CZ, Wang C, Huang ZX, Zhu SZ, Wu YY, Qiu JL. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer. World J Gastroenterol 2006; 12(13): 2011-2015 [PMID: 16610049 DOI: 10.3748/wjg.v12.i13.2011] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
11 Farber CR, Corva PM, Medrano JF. Genome-wide isolation of growth and obesity QTL using mouse speed congenic strains. BMC Genomics 2006;7:102. [PMID: 16670015 DOI: 10.1186/1471-2164-7-102] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
12 Maffei A, Segal AM, Alvarez-Perez JC, Garcia-Ocaña A, Harris PE. Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells. Mol Endocrinol 2015;29:542-57. [PMID: 25751312 DOI: 10.1210/me.2014-1273] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
13 Watt HL, Kharmate G, Kumar U. Biology of somatostatin in breast cancer. Mol Cell Endocrinol 2008;286:251-61. [PMID: 18308465 DOI: 10.1016/j.mce.2008.01.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
14 Watt HL, Rachid Z, Jean-Claude BJ. Receptor activation and inhibition in cellular response to chemotherapeutic combinational mimicries: the concept of divergent targeting. J Neurooncol 2010;100:345-61. [PMID: 20467786 DOI: 10.1007/s11060-010-0196-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Cuny T, Mohamed A, Graillon T, Roche C, Defilles C, Germanetti AL, Couderc B, Figarella-Branger D, Enjalbert A, Barlier A, Saveanu A. Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion. Mol Cell Endocrinol 2012;355:106-13. [PMID: 22348806 DOI: 10.1016/j.mce.2012.01.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
16 Moyano Crespo GD, Cecenarro LA, Perez P, Guido C, Sosa LDV, Berhard C, Aballay LR, Gutiérrez S, Petiti JP, Torres A, Mukdsi J. Association of PTP4A3 expression and tumour size in functioning pituitary adenoma: a descriptive study. J Clin Pathol 2021;74:190-3. [PMID: 32616539 DOI: 10.1136/jclinpath-2020-206728] [Reference Citation Analysis]
17 Perianes-cachero A, Canelles S, Aguado-llera D, Frago LM, Toledo-lobo MV, Carrera I, Cacabelos R, Chowen JA, Argente J, Arilla-ferreiro E, Barrios V. Reduction in Aβ-induced cell death in the hippocampus of 17β-estradiol-treated female rats is associated with an increase in IGF-I signaling and somatostatinergic tone. J Neurochem 2015;135:1257-71. [DOI: 10.1111/jnc.13381] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
18 Cattaneo MG, Gentilini D, Vicentini LM. Deregulated human glioma cell motility: Inhibitory effect of somatostatin. Molecular and Cellular Endocrinology 2006;256:34-9. [DOI: 10.1016/j.mce.2006.05.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
19 Chan MM, Chan MM, Mengshol JA, Fish DN, Chan ED. Octreotide. Chest 2013;144:1937-45. [DOI: 10.1378/chest.13-0382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
20 Ben-Shlomo A, Pichurin O, Barshop NJ, Wawrowsky KA, Taylor J, Culler MD, Chesnokova V, Liu NA, Melmed S. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation. Mol Endocrinol 2007;21:2565-78. [PMID: 17609435 DOI: 10.1210/me.2007-0081] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
21 Martel G, Dutar P, Epelbaum J, Viollet C. Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front Endocrinol (Lausanne) 2012;3:154. [PMID: 23230430 DOI: 10.3389/fendo.2012.00154] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
22 Li Q, Zhang Y, Wu N, Yin N, Sun XH, Wang Z. Activation of somatostatin receptor 5 suppresses T-type Ca2+ channels through NO/cGMP/PKG signaling pathway in rat retinal ganglion cells. Neurosci Lett 2019;708:134337. [PMID: 31220522 DOI: 10.1016/j.neulet.2019.134337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Treppiedi D, Giardino E, Catalano R, Mangili F, Vercesi P, Sala E, Locatelli M, Arosio M, Spada A, Mantovani G, Peverelli E. Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity. Molecular and Cellular Endocrinology 2019;483:31-8. [DOI: 10.1016/j.mce.2018.12.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Liu Q, Dewi DA, Liu W, Bee MS, Schonbrunn A. Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding. Mol Pharmacol 2008;73:292-304. [PMID: 17981995 DOI: 10.1124/mol.107.038570] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
25 Fazio N, Cinieri S, Lorizzo K, Squadroni M, Orlando L, Spada F, Maiello E, Bodei L, Paganelli G, Delle Fave G, de Braud F. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas. Cancer Treat Rev 2010;36 Suppl 3:S87-94. [PMID: 21129617 DOI: 10.1016/S0305-7372(10)70026-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
26 Thomas ME, Friedman NHM, Cisneros-franco JM, Ouellet L, de Villers-sidani É. The Prolonged Masking of Temporal Acoustic Inputs with Noise Drives Plasticity in the Adult Rat Auditory Cortex. Cerebral Cortex 2019;29:1032-46. [DOI: 10.1093/cercor/bhy009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
27 Englander EW, Greeley GH. Postpyloric Gastrointestinal Peptides. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 121-59. [DOI: 10.1016/b978-012088394-3/50008-8] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
28 Berardi R, Morgese F, Torniai M, Savini A, Partelli S, Rinaldi S, Caramanti M, Ferrini C, Falconi M, Cascinu S. Medical treatment for gastro-entero-pancreatic neuroendocrine tumours. World J Gastrointest Oncol 2016; 8(4): 389-401 [PMID: 27096034 DOI: 10.4251/wjgo.v8.i4.389] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
29 Holst JJ, McGill MA. Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants. Clin Drug Investig 2012;32:1-14. [PMID: 21958333 DOI: 10.2165/11595370-000000000-00000] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
30 Nardo GD, Oliva S, Aloi M, Ferrari F, Frediani S, Marcheggiano A, Cucchiara S. A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release. World J Gastroenterol 2012; 18(21): 2727-2729 [PMID: 22690084 DOI: 10.3748/wjg.v18.i21.2727] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
31 Grimberg A. Somatostatin and cancer: applying endocrinology to oncology. Cancer Biol Ther. 2004;3:731-733. [PMID: 15326367 DOI: 10.4161/cbt.3.8.1030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
32 Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J. Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol 2008;286:75-87. [PMID: 17997029 DOI: 10.1016/j.mce.2007.09.007] [Cited by in Crossref: 138] [Cited by in F6Publishing: 129] [Article Influence: 9.9] [Reference Citation Analysis]
33 Papoian R, Scherer A, Saulnier M, Staedtler F, Cordier A, Legay F, Maurer G, Staeheli J, Vonderscher J, Chibout S. VeloceGenomics: An Accelerated in Vivo Drug Discovery Approach to Rapidly Predict the Biologic, Drug-Like Activity of Compounds, Proteins, or Genes. Pharm Res 2005;22:1597-613. [DOI: 10.1007/s11095-005-6809-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 Cammalleri M, Cervia D, Langenegger D, Liu Y, Dal Monte M, Hoyer D, Bagnoli P. Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices. Eur J Neurosci 2004;20:2711-21. [PMID: 15548214 DOI: 10.1111/j.1460-9568.2004.03741.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
35 Farrell SR, Rankin DR, Brecha NC, Barnes S. Somatostatin receptor subtype 4 modulates L-type calcium channels via Gβγ and PKC signaling in rat retinal ganglion cells. Channels (Austin) 2014;8:519-27. [PMID: 25483286 DOI: 10.4161/19336950.2014.967623] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
36 Lasfer M, Vadrot N, Schally AV, Nagy A, Halmos G, Pessayre D, Feldmann G, Reyl-Desmars FJ. Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238. J Hepatol 2005;42:230-7. [PMID: 15664249 DOI: 10.1016/j.jhep.2004.10.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
37 Stec-Michalska K, Peczek L, Krakowiak A, Michalski B, Chojnacki J, Knopik-Dabrowicz A, Klupinska G, Nawrot B. Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer. J Gastroenterol Hepatol. 2008;23:424-429. [PMID: 17683502 DOI: 10.1111/j.1440-1746.2007.05094.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
38 Kharmate G, Rajput PS, Watt HL, Somvanshi RK, Chaudhari N, Qiu X, Kumar U. Dissociation of Epidermal Growth Factor Receptor and ErbB2 Heterodimers in the Presence of Somatostatin Receptor 5 Modulate Signaling Pathways. Endocrinology 2011;152:931-45. [DOI: 10.1210/en.2010-0940] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
39 Somvanshi RK, Billova S, Kharmate G, Rajput PS, Kumar U. C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling. Cell Signal 2009;21:1396-414. [PMID: 19426801 DOI: 10.1016/j.cellsig.2009.04.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
40 Lahlou H, Fanjul M, Pradayrol L, Susini C, Pyronnet S. Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol Cell Biol 2005;25:4034-45. [PMID: 15870276 DOI: 10.1128/MCB.25.10.4034-4045.2005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
41 Rajput PS, Billova S, Patel SC, Kharmate G, Somvanshi RK, Kumar U. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis. J Chem Neuroanat 2009;38:20-33. [PMID: 19465111 DOI: 10.1016/j.jchemneu.2009.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
42 Prinster SC, Hague C, Hall RA. Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance. Pharmacol Rev 2005;57:289-98. [DOI: 10.1124/pr.57.3.1] [Cited by in Crossref: 278] [Cited by in F6Publishing: 268] [Article Influence: 17.4] [Reference Citation Analysis]
43 Nakatsuka T, Fujita T, Inoue K, Kumamoto E. Activation of GIRK channels in substantia gelatinosa neurones of the adult rat spinal cord: a possible involvement of somatostatin. J Physiol 2008;586:2511-22. [PMID: 18356203 DOI: 10.1113/jphysiol.2007.146076] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
44 Leiszter K, Sipos F, Galamb O, Krenács T, Veres G, Wichmann B, Fűri I, Kalmár A, Patai ÁV, Tóth K, Valcz G, Tulassay Z, Molnár B. Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer. PLoS One 2015;10:e0118332. [PMID: 25723531 DOI: 10.1371/journal.pone.0118332] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
45 Jung Y, Oh SH, Zheng D, Shupe TD, Witek RP, Petersen BE. A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells. Lab Invest. 2006;86:477-489. [PMID: 16534498 DOI: 10.1038/labinvest.3700410] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
46 Öberg K. Somatostatin analog octreotide LAR ® in gastro–entero–pancreatic tumors. Expert Review of Anticancer Therapy 2014;9:557-66. [DOI: 10.1586/era.09.26] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
47 Watt HL, Kharmate GD, Kumar U. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Cell Signal. 2009;21:428-439. [PMID: 19070659 DOI: 10.1016/j.cellsig.2008.11.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
48 Leu FP, Nandi M. GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line. Pancreas 2010;39:1155-66. [PMID: 20531241 DOI: 10.1097/MPA.0b013e3181de8c05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
49 Zhang Y, Wu N, Li Q, Hu X, Wang L, Sun JG, Wang Z, Sun XH. Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma. Exp Eye Res 2021;204:108449. [PMID: 33465395 DOI: 10.1016/j.exer.2021.108449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Sussman CR, Wang X, Chebib FT, Torres VE. Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling. Cell Signal 2020;72:109649. [PMID: 32335259 DOI: 10.1016/j.cellsig.2020.109649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
51 Linden R, Martins RA, Silveira MS. Control of programmed cell death by neurotransmitters and neuropeptides in the developing mammalian retina. Prog Retin Eye Res 2005;24:457-91. [PMID: 15845345 DOI: 10.1016/j.preteyeres.2004.10.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
52 Bocci G, Culler MD, Fioravanti A, Orlandi P, Fasciani A, Colucci R, Taylor JE, Sadat D, Danesi R, Del Tacca M. In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists. Eur J Clin Invest 2007;37:700-8. [PMID: 17696959 DOI: 10.1111/j.1365-2362.2007.01848.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
53 Ma L, Yin L, Hu Q. Therapeutic compounds for Cushing's syndrome: a patent review (2012-2016). Expert Opin Ther Pat. 2016;26:1307-1323. [PMID: 27454103 DOI: 10.1080/13543776.2016.1217331] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Albertelli M, Arvigo M, Boschetti M, Ferone D, Gatto F, Minuto F. Somatostatin receptor pathophysiology in the neuroendocrine system. Expert Rev Endocrinol Metab 2013;8:149-57. [PMID: 30736175 DOI: 10.1586/eem.13.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Shulkes A, Baldwin GS, Giraud AS. Regulation of Gastric Acid Secretion. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1223-58. [DOI: 10.1016/b978-012088394-3/50052-0] [Cited by in Crossref: 11] [Article Influence: 0.7] [Reference Citation Analysis]
56 War SA, Somvanshi RK, Kumar U. Somatostatin receptor-3 mediated intracellular signaling and apoptosis is regulated by its cytoplasmic terminal. Biochim Biophys Acta 2011;1813:390-402. [PMID: 21194548 DOI: 10.1016/j.bbamcr.2010.12.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
57 Gatto F, Barbieri F, Arvigo M, Thellung S, Amarù J, Albertelli M, Ferone D, Florio T. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. Int J Mol Sci 2019;20:E3940. [PMID: 31412614 DOI: 10.3390/ijms20163940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
58 Chen W, Ke JB, Wu HJ, Miao Y, Li F, Yang XL, Wang Z. Somatostatin receptor-mediated suppression of gabaergic synaptic transmission in cultured rat retinal amacrine cells. Neuroscience 2014;273:118-27. [PMID: 24846611 DOI: 10.1016/j.neuroscience.2014.05.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
59 Larocca AV, Toniolo G, Tortorella S, Krokidis MG, Menounou G, Di Bella G, Chatgilialoglu C, Ferreri C. The Entrapment of Somatostatin in a Lipid Formulation: Retarded Release and Free Radical Reactivity. Molecules 2019;24:E3085. [PMID: 31450691 DOI: 10.3390/molecules24173085] [Reference Citation Analysis]
60 Martinez V. Somatostatin. Handbook of Biologically Active Peptides. Elsevier; 2013. pp. 1320-9. [DOI: 10.1016/b978-0-12-385095-9.00180-9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
61 Kharmate G, Rajput PS, Watt HL, Somvanshi RK, Chaudhari N, Qiu X, Kumar U. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011;1813:1172-89. [DOI: 10.1016/j.bbamcr.2011.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
62 Cervia D, Langenegger D, Schuepbach E, Cammalleri M, Schoeffter P, Schmid HA, Bagnoli P, Hoyer D. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors. Neuropharmacology 2005;48:881-93. [PMID: 15829258 DOI: 10.1016/j.neuropharm.2004.12.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
63 Zhao R, Zhang R, Li W, Liao Y, Tang J, Miao Q, Hao W. Genome-wide DNA methylation patterns in discordant sib pairs with alcohol dependence. Asia Pac Psychiatry 2013;5:39-50. [PMID: 23857790 DOI: 10.1111/appy.12010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
64 Gatto F, Hofland LJ. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocr Relat Cancer 2011;18:R233-51. [PMID: 22135243 DOI: 10.1530/ERC-10-0334] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
65 Ballian N, Hu M, Liu S, Brunicardi FC. Proliferation, Hyperplasia, Neogenesis, and Neoplasia in the Islets of Langerhans. Pancreas 2007;35:199-206. [DOI: 10.1097/mpa.0b013e318074c6ed] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
66 Shannon M, Green B, Willars G, Wilson J, Matthews N, Lamb J, Gillespie A, Connolly L. The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction. Toxicology Letters 2017;265:97-105. [DOI: 10.1016/j.toxlet.2016.11.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
67 Ristori C, Cammalleri M, Martini D, Pavan B, Liu Y, Casini G, Dal Monte M, Bagnoli P. Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus. Naunyn Schmiedebergs Arch Pharmacol 2008;378:563-77. [PMID: 18665350 DOI: 10.1007/s00210-008-0338-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
68 Cakir M, Dworakowska D, Grossman A. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways. J Cell Mol Med 2010;14:2570-84. [PMID: 20629989 DOI: 10.1111/j.1582-4934.2010.01125.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
69 Cai C, Li H, Kangasniemi A, Pihlajamaa T, Von Ossowski L, Kerkelä K, Schulz S, Rivera C, Keinänen K. Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics. Neuroscience 2008;157:833-43. [PMID: 18951956 DOI: 10.1016/j.neuroscience.2008.09.048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
70 Aguado-Llera D, Canelles S, Frago LM, Chowen JA, Argente J, Arilla E, Barrios V. The Protective Effects of IGF-I against β-Amyloid-related Downregulation of Hippocampal Somatostatinergic System Involve Activation of Akt and Protein Kinase A. Neuroscience 2018;374:104-18. [PMID: 29406271 DOI: 10.1016/j.neuroscience.2018.01.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Si Y, Kim S, Ou J, Lu Y, Ernst P, Chen K, Whitt J, Carter AM, Markert JM, Bibb JA, Chen H, Zhou L, Jaskula-Sztul R, Liu XM. Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy. Cancer Gene Ther 2021;28:799-812. [PMID: 32684623 DOI: 10.1038/s41417-020-0196-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
72 杨玥, 张丹华, 陈媛, 余曙光, 曾芳. 脑肠互动与针刺治疗功能性胃肠病的相关性. 世界华人消化杂志 2012; 20(6): 491-496 [DOI: 10.11569/wcjd.v20.i6.491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Kramerov AA, Saghizadeh M, Pan H, Kabosova A, Montenarh M, Ahmed K, Penn JS, Chan CK, Hinton DR, Grant MB, Ljubimov AV. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Pathol 2006;168:1722-36. [PMID: 16651637 DOI: 10.2353/ajpath.2006.050533] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
74 Tallent MK. Somatostatin in the dentate gyrus. Prog Brain Res 2007;163:265-84. [PMID: 17765724 DOI: 10.1016/S0079-6123(07)63016-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
75 Kim S, Kim H, Park D, Kim J, Hong J, Kim JS, Jung H, Kim D, Cheong E, Ko J, Um JW. Loss of IQSEC3 Disrupts GABAergic Synapse Maintenance and Decreases Somatostatin Expression in the Hippocampus. Cell Reports 2020;30:1995-2005.e5. [DOI: 10.1016/j.celrep.2020.01.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
76 Lin C, Happé H, Veraar K, Scharpfenecker M, Peters DJ; Dipak Consortium. The expression of somatostatin receptor 2 decreases during cyst growth in mice with polycystic kidney disease. Exp Biol Med (Maywood) 2018;243:1092-8. [PMID: 30261745 DOI: 10.1177/1535370218803893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Michael M, Garcia-Carbonero R, Weber MM, Lombard-Bohas C, Toumpanakis C, Hicks RJ. The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review. Oncologist 2017;22:272-85. [PMID: 28220021 DOI: 10.1634/theoncologist.2016-0305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
78 Masyuk TV, Radtke BN, Stroope AJ, Banales JM, Gradilone SA, Huang B, Masyuk AI, Hogan MC, Torres VE, Larusso NF. Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. Hepatology. 2013;58:409-421. [PMID: 23172758 DOI: 10.1002/hep.26140] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
79 Feanny MA, Fagan SP, Ballian N, Liu SH, Li Z, Wang X, Fisher W, Brunicardi FC, Belaguli NS. PDX-1 expression is associated with islet proliferation in vitro and in vivo. J Surg Res 2008;144:8-16. [PMID: 17583748 DOI: 10.1016/j.jss.2007.04.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
80 Ballian N, Brunicardi FC, Wang X. Somatostatin and its Receptors in the Development of the Endocrine Pancreas. Pancreas 2006;33:1-12. [DOI: 10.1097/01.mpa.0000226894.16817.e8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
81 Fastrez M, Marchisello C, Rassy M, Rozenberg S, Sirtaine N. Immunohistochemical Analysis of Somatostatin Receptors in Endometriosis Tissue Samples: A Retrospective Study. International Journal of Gynecological Pathology 2019;38:371-6. [DOI: 10.1097/pgp.0000000000000522] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Abdellatif AAH, Aldalaen SM, Faisal W, Tawfeek HM. Somatostatin receptors as a new active targeting sites for nanoparticles. Saudi Pharm J 2018;26:1051-9. [PMID: 30416362 DOI: 10.1016/j.jsps.2018.05.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
83 Prasoon P, Kumar R, Gautam M, Sebastian EK, Reeta KH, Ray SB. Role of somatostatin and somatostatin receptor type 2 in postincisional nociception in rats. Neuropeptides 2015;49:47-54. [PMID: 25599867 DOI: 10.1016/j.npep.2014.12.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
84 Kaszper E, Hanzély Z, Szende B, Dabasi G, Garami M, Schuler D, Hauser P. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas]. Magy Onkol 2008;52:351-5. [PMID: 19068462 DOI: 10.1556/MOnkol.52.2008.4.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 War SA, Kumar U. Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis. J Mol Signal 2012;7:5. [PMID: 22651821 DOI: 10.1186/1750-2187-7-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
86 Vitali E, Cambiaghi V, Zerbi A, Carnaghi C, Colombo P, Peverelli E, Spada A, Mantovani G, Lania AG. Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours. Endocr Relat Cancer 2016;23:181-90. [PMID: 26733502 DOI: 10.1530/ERC-15-0358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
87 Cervia D, Bagnoli P. An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacol Ther 2007;116:322-41. [PMID: 17719647 DOI: 10.1016/j.pharmthera.2007.06.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
88 Lee J, Majumder S, Chatterjee S, Muralidhar K. Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis. J Biosci 2011;36:341-54. [DOI: 10.1007/s12038-011-9073-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
89 Shupe T, Petersen BE. Potential applications for cell regulatory factors in liver progenitor cell therapy. Int J Biochem Cell Biol 2011;43:214-21. [PMID: 20851776 DOI: 10.1016/j.biocel.2010.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
90 Petrenko V, Dibner C. Cell-specific resetting of mouse islet cellular clocks by glucagon, glucagon-like peptide 1 and somatostatin. Acta Physiol (Oxf) 2018;222:e13021. [PMID: 29271578 DOI: 10.1111/apha.13021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
91 Stec-Michalska K, Peczek L, Michalski B, Adamczyk M, Chojnacki J, Nawrot B. Influence of cigarette smoking on the level of mRNA of somatostatin receptor 3 (SSTR3) in the gastric mucosa of patients with functional dyspepsia. Adv Med Sci 2010;55:53-8. [PMID: 20570798 DOI: 10.2478/v10039-010-0026-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
92 Facciolo RM, Madeo M, Alò R, Canonaco M, Dessì-fulgheri F. Neurobiological Effects of Bisphenol A May Be Mediated by Somatostatin Subtype 3 Receptors in Some Regions of the Developing Rat Brain. Toxicological Sciences 2005;88:477-84. [DOI: 10.1093/toxsci/kfi322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
93 Riaz H, Dong P, Shahzad M, Yang L. Constitutive and follicle-stimulating hormone-induced action of somatostatin receptor-2 on regulation of apoptosis and steroidogenesis in bovine granulosa cells. J Steroid Biochem Mol Biol 2014;141:150-9. [PMID: 24530462 DOI: 10.1016/j.jsbmb.2014.02.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
94 Ayiomamitis GD, Notas G, Zaravinos A, Drygiannakis I, Georgiadou M, Sfakianaki O, Mastrodimou N, Thermos K, Kouroumalis E. Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity. Oncoscience 2014;1:457-67. [PMID: 25594044 DOI: 10.18632/oncoscience.58] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]